Sucralose: assessment of teratogenic potential in the rat and the rabbit.
The teratogenic potential of sucralose was examined following gavage administration to pregnant rats and rabbits during organogenesis. Groups of 20 mated rats were dosed on days 6-15 of gestation inclusive at 500, 1000 or 2000mg/kg/day; groups of 16 to 18 inseminated rabbits were dosed on days 6 to 19 of gestation inclusive at 175, 350 or 700mg/kg/day following preliminary studies at higher doses. Concurrent control groups received vehicle alone. Rats were killed on day 21 and rabbits on day 29 of gestation. Foetuses were evaluated at necropsy and after processing for possible soft tissue and skeletal alterations. There was no evidence of teratogenicity for either species. The only observed response to treatment in rats was a slight increase in water intake. Some adult rabbits receiving 700mg/kg/day exhibited marked gastrointestinal disturbance, also seen at higher doses in preliminary studies. Gastrointestinal effects such as these occur non-specifically in response to high doses of poorly absorbed compounds, and in the present study were considered to be responsible for two maternal deaths and four abortions. Full evaluation of rabbit foetuses in the main study (up to 700mg/kg/day) and necropsy of foetuses in a preliminary study with pregnant animals (up to 1000mg/kg/day) showed no evidence of adverse foetal response to sucralose. These teratology studies in both pregnant rodent and non-rodent animal models demonstrate that maternal consumption of high levels of sucralose during the period of organogenesis has no effect on normal foetal development in the rat or rabbit.
Kille
J W
JW
McNeil Specialty Products Co., 501 George St, New Brunswick, NJ, 08903-2400, USA.
Tesh
J M
JM
McAnulty
P A
PA
Ross
F W
FW
Willoughby
C R
CR
Bailey
G P
GP
Wilby
O K
OK
Tesh
S A
SA
D000284:Administration, Oral; D000818:Animals; D001835:Body Weight; D002855:Chromatography, Thin Layer; D004435:Eating; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D005333:Fetus / Q000002:abnormalities* / Q000187:drug effects; D008297:Male; D009929:Organ Size; D010865:Pilot Projects; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D012588:Scintillation Counting; D018709:Statistics, Nonparametric; D013395:Sucrose / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000633:toxicity; D013549:Sweetening Agents / Q000008:administration & dosage / Q000633:toxicity*; D014867:Water
D013549:Sweetening Agents; D014867:Water; D013395:Sucrose; C026285:trichlorosucrose